At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- NMS Assist (device)
- How long the study runs
- Study runs about 16 months (dates as stated)
- About the drug or intervention
- NMS Assist — device: The system enables people with Parkinson's and their care partners to complete questionnaires about symptoms and burden and share that information with their care team.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 30
- Started
- 2025-08-06
- Last checked
- 2026-01
Plain English Summary
What is this study?
- • Testing a new treatment for parkinson disease
- • NA - 30 participants
- • Parkinson's can cause a wide range of non-motor symptoms (NMS), including pain and problems with mental health, memory and sleep
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with parkinson disease
Where?
- • Newcastle upon Tyne - Newcastle University
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Parkinson's can cause a wide range of non-motor symptoms (NMS), including pain and problems with mental health, memory and sleep. These affect the quality of life of people with Parkinson's (PwP) and their care partners (CP). If these issues are not recognised and managed quickly, they can result in escalating problems. Many PwP are unsure of the extent and variety of the NMS and how simple adjustments at home could improve them. We have developed a digital system to help PwP monitor their non-motor symptoms and develop skills to self-manage them. Such a tool needs to be simple to use, safe and effective. We will ask 30 PwP and CPs to use the digital tool for 6 months, and we will monitor how they use the tool. PwP and CPs will be asked if they feel more knowledgeable and confident to manage their own symptoms whilst being better able to discuss a problem with their healthcare professional. A smaller group of participants will discuss their experiences in more detail to help pinpoint aspects that work well and those needing adjustment and development. It is thought that the use of this system will result in improved quality of life and increased knowledge and confidence for managing symptoms while safely reducing the time spent by healthcare professionals on manageable non-motor symptoms.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Individuals will be eligible if they meet the following inclusion criteria:
- ✓Age 18 years or over
- ✓Be fluent in English
- ✓Able and willing to provide agreement to take part
- ✓Able and willing to comply with intervention requirements
Who cannot take part
- ✗Participants will be ineligible for the study if they meet any of the following exclusion criteria:
- ✗Previous involvement in the development or testing of the digital system
- ✗In a dependent/unequal relationship with the research or care teams or any PPI representatives
- ✗Secondary cause of Parkinsonism
- ✗Significant cognitive impairment or a diagnosis of Parkinson's disease dementia
See the full criteria
Where Is This Study? (1 UK site)
Newcastle University
Newcastle upon Tyne NE4 8EA, United Kingdom